计算生物学市场报告：2030 年趋势、预测与竞争分析

计算生物学的趋势和预测

预计到 2030 年，全球计算生物学市场将达到 128 亿美元，2024 年至 2030 年年复合成长率为 13.4%。该市场的主要驱动力是基于人工智慧的技术在药物研发中的日益使用以及对药物设计和疾病建模的兴趣日益浓厚。全球计算生物学市场的未来充满了学术、研究和商业机会。

计算生物学市场洞察

Lucintel 预测，细胞和生物模拟将在预测期内达到最高成长。

由于公共和私营部门在基因工程和开发新药方面的研发支出增加，预计在预测期内商业部门的市场将出现更高的成长。

由于拥有强大的医疗基础设施、不断增加的慢性疾病患者数量以及主要参与者的存在，北美仍然是最大的地区。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球计算生物学市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球计算生物学市场趋势（2018-2023）与预测（2024-2030）
• 全球计算生物学市场（按服务）
  • 合约
  • 公司内部
• 全球计算生物学市场（按应用）
  • 细胞和生物模拟
  • 药物研发与疾病建模
  • 临床前药物开发
  • 临床试验
  • 人体模拟软体
  • 其他的
• 按最终用途行业分類的全球计算生物学市场
  • 学术与研究
  • 商业的
  • 其他的

第4章2018-2030年分地区市场趋势及预测分析

• 全球计算生物学市场（按地区）
• 北美计算生物学市场
• 欧洲计算生物学市场
• 亚太计算生物学市场
• 其他区域计算生物学市场

第5章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第6章成长机会与策略分析

• 成长机会分析
  • 全球计算生物学市场成长机会（按服务）
  • 全球计算生物学市场成长机会（按应用）
  • 最终用途产业的全球计算生物学市场成长机会
  • 按地区分類的全球计算生物学市场成长机会
• 全球计算生物学市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球计算生物学市场的容量
  • 全球计算生物学市场的合併、收购和合资企业
  • 认证和许可

第7章主要企业概况

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

Computational Biology Trends and Forecast

The future of the global computational biology market looks promising with opportunities in the academic & research and commercial sectors. The global computational biology market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 13.4% from 2024 to 2030. The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

A more than 150-page report is developed to help in your business decisions.

Computational Biology by Segment

The study includes a forecast for the global computational biology by service, application, end use industry, and region.

Computational Biology Market by Service [Shipment Analysis by Value from 2018 to 2030]:

• Contract
• In-House

Computational Biology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cellular & Biological Simulation
• Drug Discovery & Disease Modelling
• Preclinical Drug Development
• Clinical Trials
• Human Body Simulation Software
• Others

Computational Biology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Academics & Research
• Commercial
• Others

Computational Biology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Computational Biology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies computational biology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the computational biology companies profiled in this report include-

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

Computational Biology Market Insights

Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Within this market, commercial is expected to witness higher growth over the forecast period due to increasing public and private sector spending on research and development in genetic engineering and the development of new drugs.

North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Features of the Global Computational Biology Market

Market Size Estimates: Computational biology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Computational biology market size by service, application, end use industry, and region in terms of value ($B).

Regional Analysis: Computational biology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different services, applications, end use industries, and regions for the computational biology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the computational biology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the computational biology market size?

Answer: The global computational biology market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for computational biology market?

Answer: The global computational biology market is expected to grow with a CAGR of 13.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the computational biology market?

Answer: The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

Q4. What are the major segments for computational biology market?

Answer: The future of the computational biology market looks promising with opportunities in the academic & research and commercial sectors.

Q5. Who are the key computational biology market companies?

Answer: Some of the key computational biology companies are as follows:

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

Q6. Which computational biology market segment will be the largest in future?

Answer: Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Q7. In computational biology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the computational biology market by service (contract and in-house), application (cellular & biological simulation, drug discovery & disease modelling, preclinical drug development, clinical trials, human body simulation software, and others), end use industry (academics & research, commercial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Computational Biology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Computational Biology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Computational Biology Market by Service
  • 3.3.1: Contract
  • 3.3.2: In-house
• 3.4: Global Computational Biology Market by Application
  • 3.4.1: Cellular & Biological Simulation
  • 3.4.2: Drug Discovery & Disease Modelling
  • 3.4.3: Preclinical Drug Development
  • 3.4.4: Clinical Trials
  • 3.4.5: Human Body Simulation Software
  • 3.4.6: Others
• 3.5: Global Computational Biology Market by End Use Industry
  • 3.5.1: Academics & Research
  • 3.5.2: Commercial
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Computational Biology Market by Region
• 4.2: North American Computational Biology Market
  • 4.2.1: North American Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.2.2: North American Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.3: European Computational Biology Market
  • 4.3.1: European Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.3.2: European Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.4: APAC Computational Biology Market
  • 4.4.1: APAC Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.4.2: APAC Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.5: ROW Computational Biology Market
  • 4.5.1: ROW Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.5.2: ROW Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Computational Biology Market by Service
  • 6.1.2: Growth Opportunities for the Global Computational Biology Market by Application
  • 6.1.3: Growth Opportunities for the Global Computational Biology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Computational Biology Market by Region
• 6.2: Emerging Trends in the Global Computational Biology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Computational Biology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computational Biology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Genedata
• 7.2: Rhenovia Pharma
• 7.3: Compugen
• 7.4: Chemical Computing
• 7.5: Certara
• 7.6: Nimbus Discovery
• 7.7: Rhenovia Pharma & Leadscope
• 7.8: Simulation Plus
• 7.9: Entelos
• 7.10: Insilico Biotechnology